

%201.webp)



%201.webp)




LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。



%201.webp)



%201.webp)




序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

Pakistan has established a robust regulatory framework for track and trace systems, spearheaded by the Drug Regulatory Authority of Pakistan (DRAP) and the Federal Board of Revenue (FBR). These comprehensive regulations, particularly SRO 470(I)/2017 for pharmaceuticals and the broader FBR Track and Trace System, represent Pakistan's commitment to combating counterfeit products, enhancing tax compliance, and ensuring supply chain transparency across critical sectors including pharmaceuticals, tobacco, cement, sugar, and fertilizers.

Pakistan requires all regulated pharmaceutical products to bear unique GS1 Data Matrix barcodes containing essential product information including serial numbers, batch/lot numbers, expiry dates, and manufacturer details. This machine-readable identification system enables precise tracking from production through distribution to end consumers. The serialization extends across all packaging levels—primary, secondary, and tertiary—ensuring comprehensive traceability throughout the supply chain network.
The regulations mandate that specific product data be encoded within the barcode system, including product name and description, strength and dosage form, batch numbers, expiry dates in YYMMDD format, manufacturer registration numbers, pricing information, and unique serial numbers for each sellable unit. This detailed information encoding creates a complete digital fingerprint for each product, enabling authorities to verify authenticity and track movement with unprecedented precision.
Beyond pharmaceuticals, Pakistan's track and trace system encompasses high-risk sectors including tobacco, cement, sugar, fertilizers, beverages, petroleum products, and steel industries. The FBR's integrated system uses unique identification markings, specialized tax stamps, and real-time data exchange capabilities to monitor these sectors comprehensively. This multi-sector approach demonstrates Pakistan's holistic commitment to supply chain security and revenue protection.
The regulatory framework incorporates a thoughtful implementation timeline, allowing a six-month adaptation period for pharmaceutical manufacturers and importers, with a two-year optional period for certain barcode labeling requirements. After three years, full serialization becomes mandatory across all packaging levels. The Registration Board maintains authority to grant conditional relaxations for specific products facing practical implementation challenges, ensuring regulatory compliance while accommodating industry realities.
Our team of compliance experts possesses in-depth knowledge of iTS and Turkish pharmaceutical regulations. From serialization strategies to data reporting, we guide your organization through the intricacies of compliance, ensuring a smooth and informed journey.
Leverage our state-of-the-art compliance solution, designed to integrate seamlessly with iTS requirements. Our technology ensures accuracy, efficiency, and real-time visibility, empowering your organization to meet and exceed compliance expectations.
Compliance is not just about meeting today's standards; it's about preparing for the future. Our solution is designed to evolve with regulatory changes, ensuring that your organization remains at the forefront of compliance in the dynamic Turkish pharmaceutical landscape.
We believe in transparent collaboration. Partner with us, and we'll work closely with your team to implement and maintain compliance measures. Our goal is to build a resilient, compliant, and future-ready pharmaceutical supply chain together.

.webp)
Achieving compliance with Pakistan's multi-layered track and trace requirements demands specialized expertise and strategic implementation planning. LSPedia's comprehensive software solutions are specifically designed to address the unique challenges of SRO 470(I)/2017 and FBR Track and Trace System requirements. Our platform seamlessly integrates GS1 Data Matrix generation, real-time data exchange capabilities, and multi-sector compliance monitoring, ensuring your organization meets all regulatory obligations while optimizing operational efficiency. From initial serialization setup to ongoing compliance maintenance, LSPedia provides the technological infrastructure and expert guidance necessary to navigate Pakistan's evolving regulatory environment successfully.




We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.
Stay connected with us on social media and subscribe to our newsletter to receive the latest updates, insights, and innovations from LSPedia.
Pharmaceutical serialization and barcode requirements in Pakistan are regulated by the Drug Regulatory Authority of Pakistan (DRAP). Pakistan has established a regulatory framework requiring barcode identification on pharmaceutical packaging and is progressing toward the implementation of serialization for medicines.
The regulatory foundation is defined under S.R.O. 470(I)/2017 – Drugs Labelling and Packing Rules, which introduced mandatory barcode labeling for pharmaceutical products to support identification, tracking, and verification within the supply chain.
Pakistan is currently transitioning from basic barcode identification to GS1 DataMatrix based serialization. Regulatory updates issued by DRAP indicate that the authority is moving toward the implementation of 2D barcodes with serialized identifiers on pharmaceutical packaging.
At present, Pakistan’s framework focuses primarily on product identification through barcodes and serialization readiness, and a fully operational national end to end track and trace reporting platform has not yet been publicly implemented.
Pharmaceutical products manufactured or imported for distribution in Pakistan must include machine readable barcodes on the packaging in accordance with DRAP labeling rules.
Under the current regulatory framework and draft amendments, the following barcode formats are specified:
Secondary Packaging
Secondary packaging is expected to include a GS1 DataMatrix barcode containing:
These identifiers allow each medicine package to be uniquely identified and support verification across the pharmaceutical supply chain.
Tertiary Packaging
Tertiary packaging may include GS1-128 barcodes. Where applicable, logistics units may include Serial Shipping Container Codes (SSCC) to support supply chain handling and distribution.
Human readable information printed on the packaging must match the encoded barcode data.
2017
DRAP issued S.R.O. 470(I)/2017 – Drugs Labelling and Packing Rules, introducing mandatory barcode labeling requirements for pharmaceutical products.
2025
DRAP published draft amendments expanding the barcode framework to include GS1 DataMatrix barcodes with serialization on secondary packaging and logistics identifiers on tertiary packaging.
Current Status
Pakistan has implemented barcode identification requirements and is actively progressing toward broader serialization implementation across the pharmaceutical sector.
The current DRAP regulations focus primarily on barcode labeling and serialization readiness rather than mandatory electronic reporting of supply chain events.
| Operation | Data to Report | When to Report |
Commission | GTIN, Serial, Batch, Expiry Parent SSCC, Child Serials Sender GLN, Receiver GLN, SSCC or Serial List | During packaging before shipment When creating cases or pallets Before dispatch |
ReceivingImport Clearance Supply to Pharmacy | GTIN, Serial, Batch, Expiry Parent SSCC, Child Serials Sender GLN, Receiver GLN, SSCC or Serial List | During packaging before shipment When creating cases or pallets Before dispatch |
Returns Decommission | Serial status and reference Reason and serials | When return is approved When product is destroyed or removed |
Pakistan does not currently operate a national pharmaceutical serialization reporting platform that captures supply chain transaction events such as commissioning, shipment, receiving, or dispensing.
The current regulatory framework focuses on barcode identification and serialization implementation, while broader traceability infrastructure continues to be developed.
Supply chain traceability is currently supported through company systems, packaging identification, and regulatory documentation rather than through a centralized government reporting platform.
Pakistan’s regulatory framework includes provisions for tertiary packaging identification using GS1-128 barcodes and SSCC codes.
However, aggregation at case and pallet level is not yet fully mandatory across the pharmaceutical supply chain, and implementation timelines are phased under regulatory updates.
Manufacturers and distributors may implement aggregation internally to support logistics operations and supply chain management.
We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.